Lataa...
Impact of a Clinical Pharmacy Service on the Management of Patients in a Sickle Cell Disease Outpatient Center
BACKGROUND: Ambulatory care clinical pharmacy services have expanded beyond primary care settings, but literature supporting the benefits of clinical pharmacy involvement with patients who have rare diseases such as sickle cell disease (SCD) is lacking. Hydroxyurea is the only agent approved by the...
Tallennettuna:
| Julkaisussa: | Pharmacotherapy |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5373798/ https://ncbi.nlm.nih.gov/pubmed/27639254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/phar.1834 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|